Sell

Tepid Growth & Slow Margin Expansion: Q2FY19 results came below our estimates. YoY revenue grew by a meagre 3.0% due to lower volumes. Margin performance has disappointed, EBITDA margin is recorded at 7.9% vs our estimate of 8.7% owing to pressure from higher materialcosts (64%).

Higher Valuations & Subdued Margins: ESAB reported Q2FY19 results above our estimates. Q2FY19 earnings have witnessed a 49.6% YoY growth on the back of YoY revenue growth of 31.1%supported by an EBITDA growth of 35.9%.

Low base effect, margins under pressure: Q1FY19 results came below our estimates. YoY revenue grew by 17.8% on the back of low base effect. However, Margin performance has disappointed, EBITDA margin is recorded at 7.3% vs our estimate of 10.4% owing to pressure from higher material costs (73.7%).

Improved growth & Healthy Margins: ESAB reported Q1 results above ourestimates. Q1FY19 earnings have witnessed a 61.5% YoY growth on the back of YoY revenue growth of 36.5% supported by an EBITDA growth of 65.4%.